Search research articles
Contact Us
Filters
Showing results (121-130 of 131) with videos related to
Page
of 14
Sort By:
The Journal of Pharmacology and Experimental Therapeutics
|
May 12, 2006
Methamphetamine administration reduces hippocampal vesicular monoamine transporter-2 uptake
Kristi S Rau, Elisabeth Birdsall, Trent J Volz, et al.
Synapse (New York, N.Y.)
|
March 4, 2011
Ephedrine decreases vesicular monoamine transporter-2 function
Jonathan D Ellis, Christopher L German, Elisabeth Birdsall, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
July 20, 2002
A single methamphetamine administration rapidly decreases vesicular dopamine uptake
Jeffrey M Brown, Evan L Riddle, Verónica Sandoval, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 23, 2015
Chronic Nicotine Exposure Attenuates Methamphetamine-Induced Dopaminergic Deficits
Paula L Vieira-Brock, Lisa M McFadden, Shannon M Nielsen, et al.
Plos One
|
March 4, 2024
Protocol to measure validity and reliability of colorectal, breast, cervical and lung cancer screening questions from the 2021 National Health Interview Survey: Methodology and design
Larry G Kessler, Bryan Comstock, Erin J Aiello Bowles, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 29, 2011
Methamphetamine self-administration causes persistent striatal dopaminergic alterations and mitigates the deficits caused by a subsequent methamphetamine exposure
Lisa M McFadden, Greg C Hadlock, Scott C Allen, et al.
American Journal of Epidemiology
|
February 27, 2026
Measuring the Validity of Survey Questions on Breast, Cervical, Colorectal, and Lung Cancer Screening
Larry G Kessler, Bryan Comstock, Erin J Aiello Bowles, et al.
Plos One
|
July 1, 2026
Reliability of cancer screening questions from the National Health Interview Survey
Larry G Kessler, Bryan Comstock, Erin J Aiello Bowles, et al.
Synapse (New York, N.Y.)
|
December 31, 2010
Methamphetamine treatment during development attenuates the dopaminergic deficits caused by subsequent high-dose methamphetamine administration
Lisa M McFadden, Amanda J Hoonakker, Paula L Vieira-Brock, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 4, 2011
4-Methylmethcathinone (mephedrone): neuropharmacological effects of a designer stimulant of abuse
Gregory C Hadlock, Katy M Webb, Lisa M McFadden, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 131) with videos related to
Sort By:
Page
of 14
The Journal of Pharmacology and Experimental Therapeutics
|
May 12, 2006
Methamphetamine administration reduces hippocampal vesicular monoamine transporter-2 uptake
Kristi S Rau, Elisabeth Birdsall, Trent J Volz, et al.
Synapse (New York, N.Y.)
|
March 4, 2011
Ephedrine decreases vesicular monoamine transporter-2 function
Jonathan D Ellis, Christopher L German, Elisabeth Birdsall, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
July 20, 2002
A single methamphetamine administration rapidly decreases vesicular dopamine uptake
Jeffrey M Brown, Evan L Riddle, Verónica Sandoval, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 23, 2015
Chronic Nicotine Exposure Attenuates Methamphetamine-Induced Dopaminergic Deficits
Paula L Vieira-Brock, Lisa M McFadden, Shannon M Nielsen, et al.
Plos One
|
March 4, 2024
Protocol to measure validity and reliability of colorectal, breast, cervical and lung cancer screening questions from the 2021 National Health Interview Survey: Methodology and design
Larry G Kessler, Bryan Comstock, Erin J Aiello Bowles, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 29, 2011
Methamphetamine self-administration causes persistent striatal dopaminergic alterations and mitigates the deficits caused by a subsequent methamphetamine exposure
Lisa M McFadden, Greg C Hadlock, Scott C Allen, et al.
American Journal of Epidemiology
|
February 27, 2026
Measuring the Validity of Survey Questions on Breast, Cervical, Colorectal, and Lung Cancer Screening
Larry G Kessler, Bryan Comstock, Erin J Aiello Bowles, et al.
Plos One
|
July 1, 2026
Reliability of cancer screening questions from the National Health Interview Survey
Larry G Kessler, Bryan Comstock, Erin J Aiello Bowles, et al.
Synapse (New York, N.Y.)
|
December 31, 2010
Methamphetamine treatment during development attenuates the dopaminergic deficits caused by subsequent high-dose methamphetamine administration
Lisa M McFadden, Amanda J Hoonakker, Paula L Vieira-Brock, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 4, 2011
4-Methylmethcathinone (mephedrone): neuropharmacological effects of a designer stimulant of abuse
Gregory C Hadlock, Katy M Webb, Lisa M McFadden, et al.
Page
of 14